ReleaseWire Connect

The "SON (Self-Organizing Networks) Ecosystem Market: 2015 – 2030 Industry Opportunities, Challenges, Strategies & Forecasts" report presents an in-depth assessment of the SON and associated mobile network optimization ecosystem including key market drivers, challenges, OpEx and CapEx savings potential, use cases, SON deployment case studies, future roadmap, value chain, vendor analysis and strategies. The report also presents revenue forecasts for both SON and conventional mobile network optimization, along with individual projections for 7 SON submarkets, 6 regions and 15 countries from 2015 through to 2030.

The report analyses the MRI systems market, along with the major forces driving the current market and the potential challenges that can restrain growth.

Type 2 Diabetes Market to 2019 - A Shifting Treatment Algorithm and Intensified Competition Expected to Drive Growth by 2019". There is currently a large number of blood glucose-lowering drugs in the crowded type 2 diabetes market indicated for the treatment of chronically high blood glucose. The market is led by Lantus, which achieved global sales amounting to $6.4 billion in 2012. Over the forecast period from 2012 to 2019, the safer, more efficacious newer classes of drug (GLP-1 agonists, DPP-4 Inhibitors and SGLT-2 inhibitors) are expected to capture substantial market shares, largely replacing older classes such as sulfonylureas and thiazolidinediones.

Operators in the Eagle Ford have cut 2015 capital budgets significantly due to lower crude oil prices and in the near term further development of the play will slow significantly compared to 2014.

The Global Oils and Fats market is poised to reach $177.2 billion in 2014 growing at a CAGR of 5.87% to reach $279.7 billion by 2022. Financial rise in the upcoming markets, low oil prices due to intensified competition, High-class Oils and End user knowledge in fitness are the important drivers for the enlargement of the market. Health causes due to overload expenditure, Security issues in case of food, Cost of materials are the key factors restraining the market growth. The demand lies in growth of disposable income of the consumers.

The Global Seeds Market accounted for $23.65 billion in 2014 and is poised to reach $55.3 billion by 2022 growing at a CAGR of 11.2% from 2014 to 2022. There is huge demand for seeds market due to growing population, technology driven agricultural farming and widespread use of biotechnology in seed development. The factors that are influencing the market growth are huge investments in R&D, change in science and technological advancements. Whereas factors such as high barriers to market entry and increased commodity prices are limiting the growth of the market.

The Global Chemicals for Cosmetic and Toiletry Market accounted for $21.3 billion and is expected to grow at a CAGR of 6.55% from 2014 to 2022, reaching a value of $35.4 billion by the year 2022. Demand for chemicals used in the skin care products is forecasted to increase 6.2 percent yearly to $3.4 billion by 2018. There is an increase in demand for natural or bio-based products. There are more growth opportunities for gentler products, preservatives. One of the major challenges posed by the manufacturers is to lessen the level of preservatives to avoid skin irritation.

Seasonal Influenza Vaccine Market in Asia-Pacific to 2018 - Positive Impact of Government Support Offset by Limited Production Capacity, High Investment and Strict Regulations as Barriers to New Entrants which essentially provides insights into the seasonal influenza vaccine sales forecasts for the Asia-Pacific Region until 2018. The report also delves deep into vaccination patterns for seasonal influenza in the Asia-Pacific Region. Further, the geographical distribution of seasonal influenza vaccines across Japan, Australia, New Zealand, China, Taiwan, Philippines, Hong Kong, Malaysia, India and Singapore are also provided in the report.

e-Clinical Trial Solutions Market to 2018 Growing Complexity of Clinical Trials and Increased Focus on Accuracy and Efficiency Drive Trial Sponsors to Adopt Novel Technologies, which provides key data and analysis of the major factors affecting the market for eClinical trial solutions in the pharmaceuticals industry. The report also analyzes the opportunities and threats in the eClinical trial solutions market, and the key market drivers and barriers to the adoption of eClinical trial solutions in the industry.

The Global Market for Flame Retardant Chemicals Market is valued at $6.1 billion in 2014 and is expected to reach $14.32 billion by 2022 at a Compound Annual Growth Rate (CAGR) of 11.25%. The factors that drive the market include high demand from current & emerging applications, emerging economies and advancement in technology. Whereas increasing costs and strong government regulations are major restraints of the market. Construction and automotive industry and other major end-user industries of flame retardant chemicals are on a boom globally.